New heart pump device aims to make risky procedures safer

NCT ID NCT05864248

Ongoing Disease control Sponsor: Supira Medical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a temporary heart pump called the Supira System in 71 people with severe coronary artery disease who need a high-risk procedure to open blocked arteries. The pump supports the heart for up to 4 hours during the procedure to prevent dangerous drops in blood pressure. Researchers are checking if the device is safe and works as intended.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Supira System (temporary heart pump device)
What this could lead to: If successful, this device could provide a safer way to support the heart during complex procedures, potentially reducing complications.
What could go wrong: This is an early feasibility study with only 71 participants, so results may not apply broadly. Device-related adverse events are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder heart disorder heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE (CAD) HEART DISEASES HEART FAILURE

Contacts and locations

Locations

'Instituto Do Coração de São Paulo (InCor)'

São Paulo, 5403-000, Brazil
Instituto Dante Pazzanese De Cardiologia (Dante)

São Paulo, 04012-909, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.